A Phase 1/2 Trial of CLN-081 in Patients With Non-Small Cell Lung Cancer

PHASE1/PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

284

Participants

Timeline

Start Date

October 31, 2019

Primary Completion Date

January 31, 2026

Study Completion Date

March 31, 2026

Conditions
Non Small Cell Lung CancerEGFR Exon 20 Mutation
Interventions
DRUG

CLN-081

CLN-081 tablets

Trial Locations (64)

10002

National Taiwan University Hospital, Taipei

10016

New York University Langone Health, New York

10032

Columbia University Irving Medical Center, New York

10065

Memorial Sloan Kettering Cancer Center, New York

11501

Perlmutter Cancer Center at NYU Langone Hospital - Long Island, Mineola

15232

UPMC Hillman Cancer Center, Pittsburgh

22031

Virginia Cancer Specialists, Fairfax

29425

Medical University of South Carolina, Charleston

32804

AdventHealth, Orlando

44701

Gabrail Cancer Center Research, Canton

48109

University of Michigan Health System - University Hospital, Ann Arbor

90813

Pacific Shores Medical Group, Long Beach

91010

City of Hope Comprehensive Cancer Center, Duarte

92618

City of Hope at Irvine Lennar, Irvine

92801

Pacific Cancer Medical Center, Inc, Anaheim

97213

Providence Cancer Center, Portland

97225

Providence Oncology & Hematology Care Clinic-Westside, Portland

138669

Singapore Clinical Research Institute, Singapore

169610

National Cancer Centre Singapore, Singapore

02114

Massachusetts General Hospital, Boston

07932

Summit Medical Group PA, Florham Park

Unknown

Hong Kong University - Queen Mary Hospital, Hong Kong

Azienda Ospedaliero Universitaria Careggi, Careggi

Azienda Ospedaliero Universitaria Ospedali Riuniti Umberto I, Marche

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola

IRCCS-Istituto Europeo di Oncologia, Milan

Azienda Ospedaliero Universitaria Modena, Modena

San Gerardo Hospital, Monza

Ospedale Santa Maria delle Croci, Ravenna

National Cancer Center Hospital East, Chiba

Niigata Cancer Center, Niigata

Osaka City General Hospital, Osaka

Osaka International Cancer Institute, Osaka

Shizuoka Cancer Center, Shizuoka

National Cancer Center Hospital, Tokyo

The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo

National Cancer Center, Goyang-si

Seoul National University Bundang Hospital (SNUBH), Gyeonggi-do

Gachon University Gil Medical Center, Incheon

Inha University Hospital, Incheon

Samsung Medical Center, Seoul

Asan Medical Center (AMC), Soeul

Korea University Guro Hospital, Soeul

Ajou University Hospital, Suwon

The Catholic University Of Korea St. Vincent's Hospital, Suwon

University Hospital A Coruna, A Coruña

Hospital Clinic i Provincial de Barcelona, Barcelona

Hospital Parc Tauli, Barcelona

Hospital Universitario Vall d'Hebron, Barcelona

Institut Catala d'Oncologia l'Hospitalet, Barcelona

START Barcelona, Barcelona

Complejo Hospitalario Universitario Insular Materno Infantil, Las Palmas

Hospital General Universitario Gregorio Maranon (HGUGM), Madrid

Hospital Universitario Puerta de Hierro de Majadahonda, Madrid

University Hospital Quironsalud Madrid, Madrid

Hospital Regional Universitario de Malaga, Málaga

Clinica Universidad de Navarra, Pamplona

Universitat de Valencia - Hospital Universitari i Politecnic La Fe de Valencia (Hospital La Fe Bulevar Sur), Valencia

Chang Gung Medical Foundation Chiayi Chang Gung Memorial Hospital, Chiayi City

Chung Shan Medical University Hospital, Taichung

Taichung Veterans General Hospital, Taichung

Taipei Medical University Hospital, Taipei

1066 CX

The Netherlands Cancer Institute (NKI), Amsterdam

2333 ZA

Leiden University Medical Center, Leiden

Sponsors
All Listed Sponsors
lead

Cullinan Therapeutics Inc.

INDUSTRY